USP: Second Stimuli Article on Instrument Qualification published for Comments
Recommendation

18 June 2026
Regulatory framework, interfaces and practical implications
As of early March 2022, the stimuli document "Measurement Uncertainty Evaluation Relevant to Analytical Instrument and System (AIS) Qualification - The Role of Measurement Uncertainty Concepts within the AIS - PF 48(2)" has been posted on the USP Pharmacopeial Forum website for comment. Comments and remarks on this draft can be submitted until 31 May 2022.
This draft is divided into the following chapters:
- Introduction
- AIS Uncertainty Contributions to the Analytical Procedure
- Evaluation of Measurement Uncertainty with Focus on UAIS
- Example - HPLC-UV Assay Method
- Conclusion
- References
The Stimuli document can be checked and commented on after a one-time registration on the Pharmacopeial Forum website.
Here you can also review the Stimuli article on "Analytical Instrument and System (AIS) Qualification, to support Analytical Procedure Validation over the Life Cycle- PF 48(1)" and comment on it until 31 March 2022 - as recently reported.
Related GMP News
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation
21.05.2026LCGC Article on Analytical Procedure Lifecycle Approaches

